open access

Vol 53, No 2 (2022)
Editorial
Submitted: 2022-03-21
Accepted: 2022-03-21
Get Citation

Incidence and disease prevalence for lymphoid neoplasms in Poland

Krzysztof Giannopoulos12
DOI: 10.5603/AHP.2022.0010
·
Acta Haematol Pol 2022;53(2):73-74.
Affiliations
  1. Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland
  2. Department of Hematology, St. John’s Cancer Centre, Lublin, Poland

open access

Vol 53, No 2 (2022)
EDITORIAL
Submitted: 2022-03-21
Accepted: 2022-03-21

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Incidence and disease prevalence for lymphoid neoplasms in Poland

Journal

Acta Haematologica Polonica

Issue

Vol 53, No 2 (2022)

Article type

Editorial

Pages

73-74

Page views

434

Article views/downloads

69

DOI

10.5603/AHP.2022.0010

Bibliographic record

Acta Haematol Pol 2022;53(2):73-74.

Authors

Krzysztof Giannopoulos

References (7)
  1. Lech-Marańda E, Budziszewska BK, Mikołajczyk T, et al. Incidence and prevalence of lymphatic neoplasms in Poland 2009–2015 determined on analysis of National Health Fund data used in the ‘Maps of healthcare needs — database of systemic and implementation analyses’ project. Acta Haematol Pol. 2022; 2(53): 1–2.
  2. Jurczak W, Walewski J. Mantle cell lymphoma — optimal therapy choice based on clinical trial results. Onkol Prakt Klin. 2007; 3(5): 254–258.
  3. Sant M, Allemani C, Tereanu C, et al. HAEMACARE Working Group. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010; 116(19): 3724–3734.
  4. Smith A, Crouch S, Lax S, et al. Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network. Br J Cancer. 2015; 112(9): 1575–1584.
  5. Surveillance, Epidemiology, and End Results (SEER) Program. National Cancer Institute, DCCPS, Surveillance Research Program, released December 2020. www.seer.cancer.gov (February 20, 2022).
  6. Dong Y, Shi O, Zeng Q, et al. Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol. 2020; 9: 14.
  7. https://ezdrowie.gov.pl/portal/home/zdrowe-dane/raporty/szpiczak-plazmocytowy (February 20, 2022).

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl